These 11 DE-mRNAs were then evaluated, revealing the upregulation of BUB1, BUB1B, CDC20, CDC45, CDK1, and NDC80 to be associated with a poorer HCC patient prognosis. This evidence concerns the gene NDC80 and hepatocellular carcinoma.